Parkin facilitates proteasome inhibitor-induced apoptosis via suppression of NF-κB activity in hepatocellular carcinoma
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Parkin facilitates proteasome inhibitor-induced apoptosis via suppression of NF-κB activity in hepatocellular carcinoma
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 10, Issue 10, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-09-27
DOI
10.1038/s41419-019-1881-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Overexpression of PIMREG promotes breast cancer aggressiveness via constitutive activation of NF-κB signaling
- (2019) Lili Jiang et al. EBioMedicine
- TRAIL mediates and sustains constitutive NF-κB activation in LGL leukemia
- (2018) Jun Yang et al. BLOOD
- Parkin function in Parkinson's disease
- (2018) Connor Arkinson et al. SCIENCE
- Proteasome Inhibitor Carbobenzoxy-L-Leucyl-L-Leucyl-L-Leucinal (MG132) Enhances Therapeutic Effect of Paclitaxel on Breast Cancer by Inhibiting Nuclear Factor (NF)-κB Signaling
- (2018) Yunjing Zhang et al. MEDICAL SCIENCE MONITOR
- PINK1 and PARK2 Suppress Pancreatic Tumorigenesis through Control of Mitochondrial Iron-Mediated Immunometabolism
- (2018) Changfeng Li et al. DEVELOPMENTAL CELL
- Multi-tiered pairing selectivity between E2 ubiquitin-conjugating enzymes and E3 ligases
- (2018) Ilona Turek et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Thinking small, doing big: Current success and future trends in drug delivery systems for improving cancer therapy with special focus on liver cancer
- (2018) María J. Limeres et al. Materials Science & Engineering C-Materials for Biological Applications
- Proteasome inhibitors in cancer therapy
- (2017) Elisabet E. Manasanch et al. Nature Reviews Clinical Oncology
- Proteasome-associated deubiquitinase ubiquitin-specific protease 14 regulates prostate cancer proliferation by deubiquitinating and stabilizing androgen receptor
- (2017) Yuning Liao et al. Cell Death & Disease
- Parkin targets HIF-1α for ubiquitination and degradation to inhibit breast tumor progression
- (2017) Juan Liu et al. Nature Communications
- miR-892b Silencing Activates NF- B and Promotes Aggressiveness in Breast Cancer
- (2016) L. Jiang et al. CANCER RESEARCH
- A novel nickel complex works as a proteasomal deubiquitinase inhibitor for cancer therapy
- (2016) C Zhao et al. ONCOGENE
- NF-κB dysregulation in multiple myeloma
- (2016) Geoffrey M. Matthews et al. SEMINARS IN CANCER BIOLOGY
- Structural Basis for Substrate Selectivity of the E3 Ligase COP1
- (2016) Sacha Uljon et al. STRUCTURE
- The novel AKT inhibitor afuresertib shows favorable safety, pharmacokinetics, and clinical activity in multiple myeloma
- (2014) A. Spencer et al. BLOOD
- Emerging Potential of Therapeutic Targeting of Ubiquitin-Specific Proteases in the Treatment of Cancer
- (2014) A. Pal et al. CANCER RESEARCH
- Efficacy of therapy with bortezomib in solid tumors: a review based on 32 clinical trials
- (2014) Zebo Huang et al. Future Oncology
- Melphalan and dexamethasone with or without bortezomib in newly diagnosed AL amyloidosis: a matched case–control study on 174 patients
- (2014) G Palladini et al. LEUKEMIA
- Ubiquitin-specific protease 4 promotes TNF-α-induced apoptosis by deubiquitination of RIP1 in head and neck squamous cell carcinoma
- (2013) Xiaozhi Hou et al. FEBS LETTERS
- Phase I dose escalation study of bortezomib in combination with lenalidomide in patients with myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML)
- (2013) Eyal C. Attar et al. LEUKEMIA RESEARCH
- Parkin Plays a Role in Sporadic Parkinson's Disease
- (2013) Ted M. Dawson et al. Neurodegenerative Diseases
- PARK2 Mediates Interleukin 6 and Monocyte Chemoattractant Protein 1 Production by Human Macrophages
- (2013) Louis de Léséleuc et al. PLoS Neglected Tropical Diseases
- Clinical and pharmacodynamic activity of bortezomib and decitabine in acute myeloid leukemia
- (2012) W. Blum et al. BLOOD
- Targeting the insulin-like growth factor-1 receptor to overcome bortezomib resistance in preclinical models of multiple myeloma
- (2012) D. J. Kuhn et al. BLOOD
- Parkin Pathway Activation Mitigates Glioma Cell Proliferation and Predicts Patient Survival
- (2012) C. W. S. Yeo et al. CANCER RESEARCH
- Regulation of Parkin E3 ubiquitin ligase activity
- (2012) Helen Walden et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Phosphatase and Tensin Homolog (PTEN)-induced Putative Kinase 1 (PINK1)-dependent Ubiquitination of Endogenous Parkin Attenuates Mitophagy
- (2012) Aleksandar Rakovic et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Bortezomib Added to Daunorubicin and Cytarabine During Induction Therapy and to Intermediate-Dose Cytarabine for Consolidation in Patients With Previously Untreated Acute Myeloid Leukemia Age 60 to 75 Years: CALGB (Alliance) Study 10502
- (2012) Eyal C. Attar et al. JOURNAL OF CLINICAL ONCOLOGY
- L-Carnitine Is an Endogenous HDAC Inhibitor Selectively Inhibiting Cancer Cell Growth In Vivo and In Vitro
- (2012) Hongbiao Huang et al. PLoS One
- Gambogic Acid Is a Tissue-Specific Proteasome Inhibitor In Vitro and In Vivo
- (2012) Xiaofen Li et al. Cell Reports
- Ubiquitin-specific protease 4 (USP4) targets TRAF2 and TRAF6 for deubiquitination and inhibits TNFα-induced cancer cell migration
- (2011) Ning Xiao et al. BIOCHEMICAL JOURNAL
- Chemical and Biological Evaluation of Dipeptidyl Boronic Acid Proteasome Inhibitors for Use in Prodrugs and Pro-Soft Drugs Targeting Solid Tumors
- (2011) Lawrence J. Milo et al. JOURNAL OF MEDICINAL CHEMISTRY
- Bortezomib: Understanding the Mechanism of Action
- (2011) B. Piperdi et al. MOLECULAR CANCER THERAPEUTICS
- Regulation and Function of NF-κB Transcription Factors in the Immune System
- (2009) Sivakumar Vallabhapurapu et al. Annual Review of Immunology
- USP11 negatively regulates TNFα-induced NF-κB activation by targeting on IκBα
- (2009) Wenjing Sun et al. CELLULAR SIGNALLING
- Transcriptional repression of p53 by parkin and impairment by mutations associated with autosomal recessive juvenile Parkinson's disease
- (2009) Cristine Alves da Costa et al. NATURE CELL BIOLOGY
- Somatic mutations of the Parkinson's disease–associated gene PARK2 in glioblastoma and other human malignancies
- (2009) Selvaraju Veeriah et al. NATURE GENETICS
- Molecular basis of bortezomib resistance: proteasome subunit 5 (PSMB5) gene mutation and overexpression of PSMB5 protein
- (2008) R. Oerlemans et al. BLOOD
- Treating Metastatic Solid Tumors With Bortezomib and a Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor Agonist Antibody
- (2008) A. Shanker et al. JNCI-Journal of the National Cancer Institute
- Is NF-κB a good target for cancer therapy? Hopes and pitfalls
- (2008) Véronique Baud et al. NATURE REVIEWS DRUG DISCOVERY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search